Product Overview
SS-31 50 mg (Elamipretide) is a novel mitochondria-targeting peptide designed to improve cellular energy production and reduce oxidative stress. It selectively targets the inner mitochondrial membrane, making it a unique compound in metabolic and regenerative research.
Manufactured by Dragon Pharma, SS-31 is widely studied for its potential benefits in cardiovascular health, muscle function, neuroprotection, and anti-aging applications.
Drug Class
SS-31 belongs to the class of mitochondria-targeting peptides, specifically designed to protect and optimize mitochondrial function.
Indications
Primary Uses (Research Context)
- Mitochondrial dysfunction studies
- Cardiovascular and muscle performance research
- Age-related cellular decline
Secondary Uses
- Neuroprotection
- Fatigue reduction
- Recovery enhancement
Mechanism of Action
SS-31 works by targeting mitochondrial cardiolipin:
- Stabilizes mitochondrial membranes
- Improves electron transport chain efficiency
- Reduces oxidative stress
- Enhances ATP production
Dosage & Administration
- Typical research dosing: 1–5 mg daily
- Administered via subcutaneous injection
- Duration varies depending on protocol
Note: Not approved for general therapeutic use; dosing is experimental.
Pharmacokinetics
- Rapid mitochondrial uptake
- Short plasma half-life with sustained cellular effects
- Systemic distribution with targeted mitochondrial action
Effects & Benefits
- Enhanced cellular energy production
- Reduced oxidative damage
- Improved muscle endurance
- Potential cardiovascular protection
Synergy & Stacking
SS-31 is often combined with other compounds for enhanced metabolic and recovery outcomes:
- NAD+ precursors (NMN/NR): Supports mitochondrial energy pathways
- CoQ10: Enhances electron transport chain function
- Growth hormone (HGH): Supports recovery and tissue repair
- BPC-157 / TB-500: Complements regenerative effects
Stacking strategies should be tailored to metabolic or recovery goals.
HRT/TRT Relevance
SS-31 may complement TRT protocols by improving cellular energy, recovery, and overall metabolic efficiency.
Use in Females
This peptide is non-hormonal and generally considered suitable for females in research settings.
Pre-Use Assessment
- Metabolic and cardiovascular evaluation
- Assessment of fatigue and performance status
- Review of concurrent therapies
Effectiveness
Preclinical and early clinical studies suggest SS-31 significantly improves mitochondrial function and reduces oxidative stress, though widespread clinical validation is ongoing.
Risk Management
Common Observations
- Mild injection site irritation
- Temporary fatigue or headache
Potential Risks
- Limited long-term safety data
- Unknown effects with prolonged use
Mitigation Strategies
- Use within controlled protocols
- Monitor response and tolerance
- Maintain proper dosing
What to Avoid While Using SS-31
- Improper dosing
- Combining with unverified compounds
- Poor storage or handling practices
Drug Interactions
- Limited data available
- Caution with concurrent metabolic therapies
Conclusion
SS-31 50 mg (Elamipretide) is an advanced mitochondrial peptide with promising applications in energy optimization, recovery, and anti-aging research. While highly innovative, it should be used cautiously due to limited clinical data.
What is the peptide SS-31 used for?
It is used to improve mitochondrial function and cellular energy production.
Is SS-31 peptide legal?
It is primarily available for research use and not approved for general medical use.
How much SS-31 peptide should I take?
Typical research dosing is 1–5 mg daily.
Did SS-31 get FDA-approved?
No, it is still under investigation and not fully approved.
